Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LASERMEDICAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.1% 1.5% 6.7% 2.2% 4.5% 4.4% 11.7% 11.7%   Credit score (0-100)   85 78 35 65 46 46 21 21   Credit rating   A A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   133.0 13.6 0.0 0.1 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,881 4,671 2,580 2,959 2,347 2,714 0.0 0.0   EBITDA   1,309 901 -741 542 101 -56.8 0.0 0.0   EBIT   960 453 -1,128 223 -165 -246 0.0 0.0   Pre-tax profit (PTP)   887.5 367.8 -1,205.2 153.1 -233.9 -283.3 0.0 0.0   Net earnings   686.0 281.0 -948.3 116.2 -186.9 -303.0 0.0 0.0   Pre-tax profit without non-rec. items   888 368 -1,205 153 -234 -283 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,027 2,038 1,474 1,156 889 701 0.0 0.0   Shareholders equity total   1,918 2,199 1,251 1,367 1,180 877 752 752   Interest-bearing liabilities   0.0 10.9 770 623 241 113 0.0 0.0   Balance sheet total (assets)   3,713 3,135 2,687 2,487 1,940 1,492 752 752   Net Debt   -806 -390 731 358 -159 -30.1 -752 -752     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,881 4,671 2,580 2,959 2,347 2,714 0.0 0.0   Gross profit growth   20.9% -4.3% -44.8% 14.7% -20.7% 15.6% -100.0% 0.0%   Employees   7 8 7 6 5 6 0 0   Employee growth %   0.0% 14.3% -12.5% -14.3% -16.7% 20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,713 3,135 2,687 2,487 1,940 1,492 752 752   Balance sheet change%   25.7% -15.6% -14.3% -7.4% -22.0% -23.1% -49.6% 0.0%   Added value   1,309.5 900.7 -741.2 541.7 153.8 -56.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -455 -437 -951 -637 -532 -377 -701 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.7% 9.7% -43.7% 7.5% -7.0% -9.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.8% 13.2% -38.3% 9.0% -6.9% -14.1% 0.0% 0.0%   ROI %   59.4% 21.6% -52.2% 11.6% -9.0% -20.0% 0.0% 0.0%   ROE %   43.6% 13.7% -55.0% 8.9% -14.7% -29.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.7% 70.1% 46.5% 54.9% 60.8% 58.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -61.5% -43.4% -98.7% 66.1% -157.1% 53.0% 0.0% 0.0%   Gearing %   0.0% 0.5% 61.6% 45.6% 20.4% 12.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   210.9% 1,561.8% 22.8% 11.5% 18.7% 23.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.5 0.4 0.6 1.0 0.8 0.0 0.0   Current Ratio   0.8 0.9 0.4 0.6 1.0 0.8 0.0 0.0   Cash and cash equivalent   805.9 401.4 38.7 264.5 399.8 143.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -358.5 -52.6 -847.0 -494.7 13.0 -108.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   187 113 -106 90 31 -9 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   187 113 -106 90 20 -9 0 0   EBIT / employee   137 57 -161 37 -33 -41 0 0   Net earnings / employee   98 35 -135 19 -37 -51 0 0